Early Investing in Entrepreneurs: What Makes for a Fundable Venture?

Share with your friends










Submit

Originally scheduled for April 4, 2019, this event is now postponed and will be held in the fall. Our apologies for this late change in our schedule.

As the fundraising process for early-stage startups grows ever-more competitive and and ever-more elusive, we invite you to take part in an event designed especially to answer the question: “What makes for a fundable venture?

Join the MIT Enterprise Forum of Washington, DC & Baltimore and the American University Center for Innovation on April 4th from 5:45pm until 8:45pm for an evening filled with startup pitches, startup tabling, “open mic” elevator pitches, Q&A and discussion, during which a moderator, host and panelists will all comment and share their expertise on how successful entrepreneurs achieve early-stage financing.  The event will take place at American University’s Don Myers Tech and Innovation Building Room 221 in Washington, DC.  Please note that dinner is included and parking is free after 5pm. 

Moderator: Edgar C. Harrell, EiR, Harrisburg University of Science and Technology and Managing Partner, Harrell Capital Partners

Panelists: Eric Koefoot, Founder and CEO, Public Relay Inc.; Dan Loague, President, DC Arch Angels; Judy Schramm, Founder and CEO, ProResource

Venture Presenters: Peter Tippett, Founder and CEO, Healthcelerate Inc.; Debra Cancro, Founder and CEO, VoiceVibes Inc.


Questions? Contact Mark Johnston at johnmark@alum.mit.edu

American University Center for Innovation and MIT Enterprise Forum Washington DC & Baltimore
American University Center for Innovation and MIT Enterprise Forum Washington DC & Baltimore

March 13 2019 New Neuroscience Opportunities in France and the U.S.

Share with your friends










Submit

Neuroscience research continually provides insight in to improving the human condition. Today, more than ever before there are new business opportunities to bridge science and engineering to help people. Given the complexity of the human brain, it is no small undertaking and often involves academic research, government support, and a determined innovator to create a successful business proposition.

Please join us at the Washington, D.C. French Embassy on Wednesday, March 13 from 6-9pm to hear leaders from France and the U.S. present their perspectives on the public private partnerships that are often essential in creating the opportunities for new businesses in healthcare.

Dr. Oliver Blin, of ISERM and IMI and Stephanie Fertig, SBIR Project Manager, National Institute of Neurological Disorders & Stroke at NIH will give short presentations on the state of neuroscience. They will then be joined by Dr. John Reppas, Director of Public Policy of the Neurotechnology Industry Organization, for a conversation about public-private partnerships.

We will take a break for light refreshments, including French wine.

Dr. Kenneth Carter, Executive Chairman at Neuralstem—a company approved for an FDA phase 1 trial—will discuss his experience as an experienced entrepreneur in this field where it can take a long time to get your product to market.

After a networking break, we will hear several short presentations from entrepreneurs who have started new companies: Dr. Samantha Scott of JuneBrain, Sam Jazzo of Kinometrix, and Dr. Dan Gura of AlgometRx.